Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
While the FDA approved doses of 0.5 mg and 1.0 mg for diabetes management, the agency has also issued warnings about potential risks including pancreatitis, thyroid cancer concerns based on animal studies, and other serious adverse events
N Engl J Med (2017) 376(24):236775
Results can usually be seen within two to three days after injection and can last for up to four months
Its clinical studies and applications have shown that the safety and effectiveness of Liraglutide in long-term use make it an important tool in the field of obesity and diabetes treatment.
US$ 27.26
US$ 23.71
US$ 20.55
